HUP9900659A2 - Use of alendronate for prevention of osteoporosis - Google Patents

Use of alendronate for prevention of osteoporosis

Info

Publication number
HUP9900659A2
HUP9900659A2 HU9900659A HUP9900659A HUP9900659A2 HU P9900659 A2 HUP9900659 A2 HU P9900659A2 HU 9900659 A HU9900659 A HU 9900659A HU P9900659 A HUP9900659 A HU P9900659A HU P9900659 A2 HUP9900659 A2 HU P9900659A2
Authority
HU
Hungary
Prior art keywords
alendronate
prevention
osteoporosis
hydroxybutylidene
bisphosphonate
Prior art date
Application number
HU9900659A
Other languages
Hungarian (hu)
Inventor
Ashley J. Yates
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of HUP9900659A2 publication Critical patent/HUP9900659A2/en
Publication of HUP9900659A3 publication Critical patent/HUP9900659A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A találmány tárgya alendronát, azaz 4-amino-1-hidroxi-butilidén-1,1-biszfoszfonát alkalmazása a nők korai posztmenopauzálisoszteoporózisának megelőzését szolgáló gyógyszer előállítására. ÓThe subject of the invention is the use of alendronate, i.e. 4-amino-1-hydroxybutylidene-1,1-bisphosphonate, for the production of a medicine for the prevention of early postmenopausal osteoporosis in women. HE

HU9900659A 1995-06-02 1996-05-29 Use of alendronate for prevention of osteoporosis HUP9900659A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (2)

Publication Number Publication Date
HUP9900659A2 true HUP9900659A2 (en) 2001-04-28
HUP9900659A3 HUP9900659A3 (en) 2002-12-28

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900659A HUP9900659A3 (en) 1995-06-02 1996-05-29 Use of alendronate for prevention of osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (en)
JP (1) JPH10506648A (en)
KR (1) KR19990022436A (en)
CN (1) CN1192685A (en)
AU (1) AU709196B2 (en)
BG (1) BG63103B1 (en)
BR (1) BR9609020A (en)
CA (1) CA2222318A1 (en)
CZ (1) CZ381197A3 (en)
EA (1) EA000677B1 (en)
EE (1) EE03306B1 (en)
HU (1) HUP9900659A3 (en)
IL (1) IL118422A0 (en)
IS (1) IS4617A (en)
NO (1) NO975527L (en)
NZ (1) NZ308935A (en)
PL (1) PL323669A1 (en)
SK (1) SK159597A3 (en)
TR (1) TR199701482T1 (en)
WO (1) WO1996038156A1 (en)
ZA (1) ZA964465B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (en) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
EP1392325B1 (en) * 2001-05-02 2006-06-21 Novartis AG Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
JP2010043119A (en) * 2009-10-16 2010-02-25 Gador Sa Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
KR102472749B1 (en) * 2022-01-18 2022-12-02 주식회사 위엔씨 Manufacturing method of adsorption material with harmful gas removal antibacterial and deodorizing functions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
JPH10506648A (en) 1998-06-30
NO975527D0 (en) 1997-12-01
BG63103B1 (en) 2001-04-30
CN1192685A (en) 1998-09-09
NZ308935A (en) 2000-07-28
TR199701482T1 (en) 1998-03-21
IL118422A0 (en) 1996-09-12
KR19990022436A (en) 1999-03-25
EE03306B1 (en) 2000-12-15
CA2222318A1 (en) 1996-12-05
AU709196B2 (en) 1999-08-26
EA000677B1 (en) 2000-02-28
AU5882496A (en) 1996-12-18
ZA964465B (en) 1996-12-11
WO1996038156A1 (en) 1996-12-05
BG102060A (en) 1998-07-31
HUP9900659A3 (en) 2002-12-28
EA199700449A1 (en) 1998-06-25
BR9609020A (en) 1999-07-06
IS4617A (en) 1997-11-19
EP0828496A1 (en) 1998-03-18
NO975527L (en) 1997-12-01
CZ381197A3 (en) 1998-06-17
PL323669A1 (en) 1998-04-14
SK159597A3 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
MX9805253A (en) Vitronectin receptor antagonists.
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
DK0859889T3 (en) Wear unit for the digging edge of a digging device
EA199700183A1 (en) METHOD OF REDUCING THE RISK OF NON-VERTEBRAL BONE FRACTURES
IT1278358B1 (en) SOLE FOR FOOTWEAR.
DK0756484T3 (en) Wet granulation formulation for diphosphonic acids
HUP9900659A2 (en) Use of alendronate for prevention of osteoporosis
MY126476A (en) 2-methyl-thieno-benzodiazepine formulation
AU1160700A (en) Ppar gamma ligands
BG103649A (en) Method for the preparation of eprosartan
EP0837863A4 (en) Disodium alendronate formulations
BG103650A (en) Method for the preparation of eprosartan
ZA200110450B (en) Oral preparations of etidronate disodium.
FR2739533B1 (en) SOLE FOR FOOTWEAR
FR2710518B1 (en) Set for placing a prosthesis formed from a flexible tissue.
DE29514656U1 (en) Floor plate for a cavity floor
MX9603140A (en) Fast disintegration medicament based on tramadol or a tramadol salt.
GR1002390B (en) Moulding system for concrete coated walls.
IT240826Y1 (en) FOOTWEAR FOR THE PRACTICE OF A SPORT BY SLIP
FR2704129B1 (en) INDIVIDUAL URINAL FOR MEN.
MX9705723A (en) Transdermal formulation.
IT1278184B1 (en) METHOD FOR THE REALIZATION OF FOOTWEAR SOLES
IT1281441B1 (en) PROCEDURE FOR THE MANUFACTURE OF SHOES
ITVR950016V0 (en) BOX-EXHIBITOR PARTICULARLY FOR FOOTWEAR
ITBO950044U1 (en) FOOT OR FOOTWEAR